181 related articles for article (PubMed ID: 31022269)
1. A negative role for the interleukin-2-inducible T-cell kinase (ITK) in human Foxp3+ TREG differentiation.
Mamontov P; Eberwine RA; Perrigoue J; Das A; Friedman JR; Mora JR
PLoS One; 2019; 14(4):e0215963. PubMed ID: 31022269
[TBL] [Abstract][Full Text] [Related]
2. Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells.
Eken A; Cansever M; Somekh I; Mizoguchi Y; Zietara N; Okus FZ; Erdem S; Canatan H; Akyol S; Ozcan A; Karakukcu M; Hollizeck S; Rohlfs M; Unal E; Klein C; Patiroglu T
J Clin Immunol; 2019 May; 39(4):391-400. PubMed ID: 31025232
[TBL] [Abstract][Full Text] [Related]
3. Tuning T helper cell differentiation by ITK.
Elmore JP; McGee MC; Nidetz NF; Anannya O; Huang W; August A
Biochem Soc Trans; 2020 Feb; 48(1):179-185. PubMed ID: 32049330
[TBL] [Abstract][Full Text] [Related]
4. Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17/Treg immune responses and reduction of oxidative stress.
Nadeem A; Al-Harbi NO; Ahmad SF; Al-Harbi MM; Alhamed AS; Alfardan AS; Assiri MA; Ibrahim KE; Albassam H
Int Immunopharmacol; 2020 Jun; 83():106369. PubMed ID: 32163900
[TBL] [Abstract][Full Text] [Related]
5. Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.
Zhong Y; Dong S; Strattan E; Ren L; Butchar JP; Thornton K; Mishra A; Porcu P; Bradshaw JM; Bisconte A; Owens TD; Verner E; Brameld KA; Funk JO; Hill RJ; Johnson AJ; Dubovsky JA
J Biol Chem; 2015 Mar; 290(10):5960-78. PubMed ID: 25593320
[TBL] [Abstract][Full Text] [Related]
6. A Small Molecule Inhibitor of ITK and RLK Impairs Th1 Differentiation and Prevents Colitis Disease Progression.
Cho HS; Shin HM; Haberstock-Debic H; Xing Y; Owens TD; Funk JO; Hill RJ; Bradshaw JM; Berg LJ
J Immunol; 2015 Nov; 195(10):4822-31. PubMed ID: 26466958
[TBL] [Abstract][Full Text] [Related]
7. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells.
Gomez-Rodriguez J; Wohlfert EA; Handon R; Meylan F; Wu JZ; Anderson SM; Kirby MR; Belkaid Y; Schwartzberg PL
J Exp Med; 2014 Mar; 211(3):529-43. PubMed ID: 24534190
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
9. P21-activated kinase 2 is essential in maintenance of peripheral Foxp3
Choi J; Pease DR; Chen S; Zhang B; Phee H
Immunology; 2018 Jun; 154(2):309-321. PubMed ID: 29297928
[TBL] [Abstract][Full Text] [Related]
10. IL-2-inducible T cell kinase tunes T regulatory cell development and is required for suppressive function.
Huang W; Jeong AR; Kannan AK; Huang L; August A
J Immunol; 2014 Sep; 193(5):2267-72. PubMed ID: 25063868
[TBL] [Abstract][Full Text] [Related]
11. Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet.
Miller AT; Wilcox HM; Lai Z; Berg LJ
Immunity; 2004 Jul; 21(1):67-80. PubMed ID: 15345221
[TBL] [Abstract][Full Text] [Related]
12. The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells.
Atherly LO; Lucas JA; Felices M; Yin CC; Reiner SL; Berg LJ
Immunity; 2006 Jul; 25(1):79-91. PubMed ID: 16860759
[TBL] [Abstract][Full Text] [Related]
13. Role of ITK signaling in acute kidney injury in mice: Amelioration of acute kidney injury associated clinical parameters and attenuation of inflammatory transcription factor signaling in CD4+ T cells by ITK inhibition.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Sarawi W; Attia SM; Alasmari AF; Alqarni SA; Alfradan AS; Bakheet SA; Al-Harbi MM
Int Immunopharmacol; 2021 Oct; 99():108028. PubMed ID: 34365077
[TBL] [Abstract][Full Text] [Related]
14. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
[TBL] [Abstract][Full Text] [Related]
15. The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival.
Felices M; Berg LJ
J Immunol; 2008 Mar; 180(5):3007-18. PubMed ID: 18292523
[TBL] [Abstract][Full Text] [Related]
16. Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3⁺ regulatory T cells in skin-transplanted mice.
Gajardo T; Morales RA; Campos-Mora M; Campos-Acuña J; Pino-Lagos K
Immunology; 2015 Sep; 146(1):81-8. PubMed ID: 25988395
[TBL] [Abstract][Full Text] [Related]
17. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
18. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
19. ITK signaling regulates a switch between T helper 17 and T regulatory cell lineages via a calcium-mediated pathway.
Anannya O; Huang W; August A
bioRxiv; 2023 Apr; ():. PubMed ID: 37066370
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells.
Raffin C; Raimbaud I; Valmori D; Ayyoub M
J Immunol; 2011 Nov; 187(10):5196-202. PubMed ID: 21998454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
